TYPHARM DEVELOPMENTS LIMITED
Company number 08272004 · Active · Norwich NR13 6JY
TYPHARM DEVELOPMENTS LIMITED is an active private limited company (company number 08272004) incorporated on 29 October 2012, registered in Norwich. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest small accounts cover the period ending 31 March 2025, showing net assets of £15.91m and cash of £5,844, with 2 employees on average. Net assets rose 38% on the prior period (£11.53m).
By net assets it sits in the top quarter of 85 comparable companies in Other (median £7,540, upper quartile £306k).
Key dates
- Incorporated
- 29 October 2012
- Next accounts due
- 31 December 2026 — in 77 days
- Confirmation statement due
- 12 November 2026 — in 28 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Total Exemption Full
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 March 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £15.91m | £5,844 | £16.10m | £46k | — | — | 2 |
| 31 March 2024 | £11.53m | £5.02m | £6.66m | £9,839 | — | — | 2 |
- Current ratio
- 348.84 — comfortable
- Cash per employee
- £2,922
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 84/100 (grade A)
- +10 Positive net assets — Net assets £15,912,117 at 2025-03-31
- +8 Net assets growing — +38.1% vs prior period
- +8 Comfortable liquidity — Current ratio 348.84
- +8 Established — Incorporated 2012-10-29 (14 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr Chandrakant Vallabhdas Ondhia — owns 25–50% of shares; holds 25–50% of voting rights · since 6 April 2016
- Mrs Parveen Chandrakant Ondhia — owns 25–50% of shares; holds 25–50% of voting rights · since 21 March 2023
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in the UK
Same activity (manufacture of basic pharmaceutical products), closest in incorporation date.
- CAMBRIDGE HEALTHCARE SUPPLIES 2012 LIMITED — Wymondham, inc. Oct 2012
- CATALENT MTI PHARMA SOLUTIONS LIMITED — Swindon, inc. Dec 2012
- A & E HEALTHCARE LTD — Dumfries, inc. Aug 2012
- YORKSHIRE HYGIENE SOLUTIONS LIMITED — Northallerton, inc. Aug 2012
- INDIVIOR EU LIMITED — Hull, inc. Jun 2012
- DRUGLAB118 LTD — Darlington, inc. Mar 2013
Reminders for TYPHARM DEVELOPMENTS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.